Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial.

Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial.

Item
http://www.wikidata.org/entity/Q37679282
Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends.Regaining the response to erythropoietin following azacitidine in chronic myelomonocytic leukemia previously evolved from refractory anemia.A randomized phase II trial of azacitidine +/- epoetin-β in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents.The clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes.Hypomethylating agent combination strategies in myelodysplastic syndromes: hopes and shortcomings.Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data from Prospective Studies.Systematic review of azacitidine regimens in myelodysplastic syndrome and acute myeloid leukemia.More is less, less is more, or does it really matter? The curious case of impact of azacitidine administration schedules on outcomes in patients with myelodysplastic syndromes.Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion.Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia.
P2860

Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial.

Item
http://www.wikidata.org/entity/Q37679282
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Limited clinical efficacy of a ...... ordic NMDSG08A phase II trial.
@en
Limited clinical efficacy of a ...... ordic NMDSG08A phase II trial.
@nl
type
label
Limited clinical efficacy of a ...... ordic NMDSG08A phase II trial.
@en
Limited clinical efficacy of a ...... ordic NMDSG08A phase II trial.
@nl
prefLabel
Limited clinical efficacy of a ...... ordic NMDSG08A phase II trial.
@en
Limited clinical efficacy of a ...... ordic NMDSG08A phase II trial.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Limited clinical efficacy of a ...... ordic NMDSG08A phase II trial.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932